Ineffectiveness of Cefoxitin and Doxycycline for Treating Mycoplasma Genitalium in Pelvic Inflammatory Disease
Author Information
Author(s): Catherine L Haggerty, Patricia A Totten, Sofia G Astete, Sharon Lee, Sarah L Hoferka, Rebecca B Ness
Primary Institution: University of Pittsburgh
Hypothesis
Is Mycoplasma genitalium associated with treatment failure in pelvic inflammatory disease when treated with cefoxitin and doxycycline?
Conclusion
Mycoplasma genitalium is linked to endometritis and short-term treatment failure in pelvic inflammatory disease, indicating that cefoxitin and doxycycline are ineffective for treating this infection.
Supporting Evidence
- 15% of women tested positive for Mycoplasma genitalium at baseline.
- 41% of women with a positive baseline test remained positive 30 days after treatment.
- Women with Mycoplasma genitalium had a 4.6 times higher risk of treatment failure.
Takeaway
This study found that a common treatment for pelvic infections doesn't work well for a specific germ called Mycoplasma genitalium, which can cause more problems.
Methodology
The study analyzed cervical and endometrial specimens from women treated for pelvic inflammatory disease to assess the presence of Mycoplasma genitalium and its association with treatment outcomes.
Potential Biases
Possible misclassification of reproductive outcomes due to reliance on self-reported data and loss to follow-up.
Limitations
The study may have biases due to reliance on self-reported data and potential confounding from other infections.
Participant Demographics
Women aged 14 to 37 years, primarily from urban US settings, with a significant proportion being African American and having a history of STDs.
Statistical Information
P-Value
0.0005
Confidence Interval
95% CI 1.5 to 6.1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website